{"id":6393,"date":"2018-12-19T13:56:27","date_gmt":"2018-12-19T13:56:27","guid":{"rendered":"https:\/\/www.openbusinesscouncil.org\/?p=6393"},"modified":"2022-05-04T21:37:57","modified_gmt":"2022-05-04T21:37:57","slug":"healthtech-big-data-and-ai-to-help-to-drive-innovation-grow-revenues-and-better-efficiency-in-2019","status":"publish","type":"post","link":"https:\/\/www.footballthink.com\/healthtech-big-data-and-ai-to-help-to-drive-innovation-grow-revenues-and-better-efficiency-in-2019\/","title":{"rendered":"Healthtech: Big Data And AI To Drive Innovation, Grow Revenues And Better Efficiency In 2019"},"content":{"rendered":"
\"Healthcare
Healthtech: Big Data And AI To Drive Innovation, Grow Revenues And Better Efficiency In 2019<\/figcaption><\/figure>\n

Healthtech will rise to prominence in 2019 as Big Data and Artificial Intelligence (AI) become a transformational force in healthcare, says GlobalData, a data and analytics company.<\/p>\n

The company\u2019s latest annual outlook report, \u2018The State of the Biopharmaceutical Industry \u2013 2019\u2019<\/strong>, reveals that 38% of global industry respondents believe that Big Data will have the greatest technology impact on the pharmaceutical industry in 2019.<\/p>\n

\n

Increasingly high volumes of data are required for all decisions and Big Data will not only alter the regulatory process as we know it, but payers will increasingly require this evidence as a pre-requisite for reimbursement. Bonnie Bain PhD, Global Head of Pharma at GlobalData<\/em><\/p><\/blockquote>\n<\/blockquote>\n

Compared with other industries, healthcare adoption of Big Data has been slow but its use will increase dramatically in 2019 across a number of core functions, namely;<\/p>\n